MedPath

pathology research of secondary osteoporosis in adult patients with type 1 diabetes mellitus: bone microarchitecture assessed by HR-pQCT

Not Applicable
Recruiting
Conditions
type1 diabete mellitus
Registration Number
JPRN-UMIN000031946
Lead Sponsor
agasaki University Hospital Department of Endocrinology and Metabolism
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.a patient with type2 diabetes mellitus 2.a patient who takes current or past treatment for osteoporosis such as teriparatide, bisphosphonates, and anti-RANKL antibody. 3.a patient who takes a drug such as steroid, anticonvulsant, or hormone replacement therapy 4.a patient with a malignat tumor 5.a patient who is pregnant, may be pregnant, or breastfeed 6.a patient whose alchohol consumption over 20g/day 7.a smoker 8.a patient who participates another clinical research within 6 months 9.a patient who is determined as inappropriate as a subject for other reasons by investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We investigate bone microarchitecture assessed by HR-pQCT in adult patients with type1 diabetes mellitus. And we compare them with healthy subjects.
Secondary Outcome Measures
NameTimeMethod
We compare the relationship between bone microarchitecture and metabolic markers with healthy subjects.
© Copyright 2025. All Rights Reserved by MedPath